ESR1 and breast carcinoma: To help shed light on the issue, we evaluated hormone-related risk factors for breast cancer by receptor subtypes (ER+PR+ and ER- PR-) in a large study of women aged 20 to 49 years, using both case–control and case–case comparisons.